TR200401462T4 - Torsemid modifikasyonu II' yi içeren dengeli bir farmasötik formülasyonu - Google Patents

Torsemid modifikasyonu II' yi içeren dengeli bir farmasötik formülasyonu

Info

Publication number
TR200401462T4
TR200401462T4 TR2004/01462T TR200401462T TR200401462T4 TR 200401462 T4 TR200401462 T4 TR 200401462T4 TR 2004/01462 T TR2004/01462 T TR 2004/01462T TR 200401462 T TR200401462 T TR 200401462T TR 200401462 T4 TR200401462 T4 TR 200401462T4
Authority
TR
Turkey
Prior art keywords
torsemide modification
stable pharmaceutical
high purity
pharmaceutical formulation
modification
Prior art date
Application number
TR2004/01462T
Other languages
English (en)
Inventor
Leibovici Minutza
Tenengauzer Ruth
Kopel Mira
Aronhime Judith
Kordova Marco
Original Assignee
Teva Pharmaceutical Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27359046&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200401462(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharmaceutical Industries Ltd. filed Critical Teva Pharmaceutical Industries Ltd.
Publication of TR200401462T4 publication Critical patent/TR200401462T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Yüksek safliktaki torsemid modifikasyonu II' nin oral yoldan uygulanmasi için yeni, dengeli farmasötik formülasyonlari açiklanmistir. Bu formülasyonlar, yüksek safliktaki torsemid modifikasyonu II' yi, suda sabit ve yüksek safliktaki bir oranda salarlar ve buradaki yüksek safliktaki torsemid modifikasyonu II, zaman içinde torsemid modifikasyonu I halinde yeniden düzenlenemez. Bunlarin imalati için yöntemler de açiklanmistir.
TR2004/01462T 2000-02-17 2001-02-21 Torsemid modifikasyonu II' yi içeren dengeli bir farmasötik formülasyonu TR200401462T4 (tr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18328800P 2000-02-17 2000-02-17
PCT/US2001/005577 WO2002067935A1 (en) 2000-02-17 2001-02-21 A stable pharmaceutical formulation comprising torsemide modification ii
US09/789,424 US6482417B2 (en) 2000-02-17 2001-02-21 Stable pharmaceutical formulation comprising torsemide modification II

Publications (1)

Publication Number Publication Date
TR200401462T4 true TR200401462T4 (tr) 2004-08-23

Family

ID=27359046

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2004/01462T TR200401462T4 (tr) 2000-02-17 2001-02-21 Torsemid modifikasyonu II' yi içeren dengeli bir farmasötik formülasyonu

Country Status (20)

Country Link
US (1) US6482417B2 (tr)
EP (1) EP1292303B1 (tr)
JP (1) JP2004522780A (tr)
CN (1) CN1505512A (tr)
AT (1) ATE266404T1 (tr)
CA (1) CA2410802A1 (tr)
DE (2) DE1292303T1 (tr)
DK (1) DK1292303T3 (tr)
ES (1) ES2193007T3 (tr)
HR (1) HRP20030762A2 (tr)
HU (1) HUP0600143A2 (tr)
IL (1) IL157539A0 (tr)
IS (1) IS6919A (tr)
MX (1) MXPA03007908A (tr)
NO (1) NO20033699L (tr)
PT (1) PT1292303E (tr)
SI (1) SI1292303T1 (tr)
SK (1) SK11632003A3 (tr)
TR (1) TR200401462T4 (tr)
WO (1) WO2002067935A1 (tr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10013289A1 (de) * 2000-03-17 2001-09-20 Knoll Ag Torasemid enthaltende pharmazeutische Zubereitungen
US20030022921A1 (en) * 2001-02-21 2003-01-30 Minutza Leibovici Stable pharmaceutical formulation comprising torsemide modification II
ITMI20020639A1 (it) * 2002-03-27 2003-09-29 Cosma S P A Composizioni farmaceutiche comprendenti come principio attivo 1-isopropil-3°(4-m-toluidino-3-pridil)sulfonil!-urea
WO2005044187A2 (en) * 2003-10-28 2005-05-19 Glaxo Group Limited Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
ES2244324B1 (es) * 2004-03-25 2006-11-16 Ferrer Internacional, S.A. Composiciones diureticas de liberacion prolongada.
CN100421662C (zh) * 2005-11-08 2008-10-01 周卓和 托拉塞米分散片及其制备方法和应用
CN100372534C (zh) * 2006-04-20 2008-03-05 南京海辰药业有限公司 托拉塞米冻干制剂及制备方法
US20080213362A1 (en) * 2007-02-02 2008-09-04 Lawrence Solomon Compositions and methods using torsemide
CN106038500A (zh) * 2016-05-26 2016-10-26 南京正科医药股份有限公司 一种托拉塞米片
KR20240052937A (ko) * 2021-07-20 2024-04-23 미네랄리스 테라퓨틱스, 아이엔씨. 이치환된 1, 2, 4-트리아진 화합물의 염을 포함하는 가용성 약제학적 조성물
GR1010905B (el) * 2024-04-15 2025-03-10 Win Medica Φαρμακευτικη Ανωνυμη Εταιρεια, Δισκιο που περιεχει τορασεμιδη

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1477664A (en) 1974-04-17 1977-06-22 Christiaens Sa A Pyridine derivatives
DE3529529A1 (de) 1985-08-17 1987-02-19 Boehringer Mannheim Gmbh Verfahren zur herstellung einer stabilen modifikation von torasemid
DE69624559T2 (de) * 1995-02-28 2003-07-10 Aventis Pharmaceuticals Inc., Bridgewater Arzneizubereitungen für piperidinalkanolderivate
US5914336A (en) * 1998-06-02 1999-06-22 Boehringer Mannheim Gmbh Method of controlling the serum solubility of orally administered torasemide and composition relating thereto
KR20020025217A (ko) * 1999-08-11 2002-04-03 추후보정 토르세미드 동질이상

Also Published As

Publication number Publication date
MXPA03007908A (es) 2004-12-06
SK11632003A3 (sk) 2004-04-06
DE1292303T1 (de) 2003-09-18
JP2004522780A (ja) 2004-07-29
NO20033699D0 (no) 2003-08-20
PT1292303E (pt) 2004-09-30
IS6919A (is) 2003-08-20
IL157539A0 (en) 2004-03-28
ES2193007T1 (es) 2003-11-01
CA2410802A1 (en) 2002-09-06
HRP20030762A2 (en) 2005-08-31
WO2002067935A1 (en) 2002-09-06
SI1292303T1 (en) 2004-10-31
HUP0600143A2 (en) 2006-10-28
ATE266404T1 (de) 2004-05-15
US20020035135A1 (en) 2002-03-21
EP1292303A1 (en) 2003-03-19
DE60103276T2 (de) 2005-06-23
NO20033699L (no) 2003-10-10
EP1292303A4 (en) 2003-07-09
DK1292303T3 (da) 2004-09-06
DE60103276D1 (de) 2004-06-17
US6482417B2 (en) 2002-11-19
CN1505512A (zh) 2004-06-16
ES2193007T3 (es) 2004-11-01
EP1292303B1 (en) 2004-05-12

Similar Documents

Publication Publication Date Title
DK1157037T3 (da) GCSF-konjugater
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
IL153297A0 (en) Compounds and compositions for delivering active agents
TR200100931T2 (tr) Yeni sürekli salınımlı oral formülasyonlar
PL347671A1 (en) Compounds and compositions for delivering active agents
MXPA01008611A (es) Compuestos y composiciones para suministrar agentes activos.
BG105564A (en) Galantamine-containing composition with controlled release
SE9504661D0 (sv) New compounds
EP1049459A4 (en) ORAL LIQUID COMPOSITIONS
YU57600A (sh) Derivarti biciklične hidroksaminske kiseline
DE60123384D1 (de) Dosierungsform des typs "hülle und kern" mit einer wirkstofffreisetzung, die sich der nullten ordnung annähert
DE69809074D1 (de) Herstellung von arzneimitteln
DK1093819T3 (da) Forbindelse og præparat til tilförsel af aktive midler
SE0102843D0 (sv) Stabilized oral pharmaceutical composition containing lodide and lodate and method
GEP20063972B (en) Streptogramin derivatives, preparation and compositions containing them
IL157539A0 (en) A stable pharmaceutical formulation comprising torsemide modification ii
DE60226896D1 (de) Herstellung von f(ab')2 fragmenten in saügetierzelle
SE9504662D0 (sv) New compounds
DE69431662D1 (de) Stabilisierte tablettenformulierung
MEP55908A (en) Utilzation of powder preparations containig hydroxypvridones for treating leg ulcers and decubitus ulcers
TR199900013T2 (tr) Yeni bilesikler.
SE9803107D0 (sv) Novel Compunds
MX9602772A (es) Nueva forma galenica de derivados de 5-nitroimidazol que es efectiva para el tratamiento de parasitos e infecciones de todo el tracto gastrointestinal.
NZ331374A (en) Phenanthridine compounds and pharmaceutical compositions thereof
SE9803277D0 (sv) Novel compounds